5-Aminosalicylates Drugs Market Is Projected to increase at a CAGR of around 3.5% during 2023 to 2031: Exclusive report by Growth Plus Reports

Newark, New Castle, USA, May 25, 2023 (GLOBE NEWSWIRE) -- The market analysis of the global 5-aminosalicylates drugs market was conducted by Growth Plus Reports in 2022. The market is expected to hit a revenue CAGR of 3.5% during the forecast period from 2023 to 2031.

Analysis of the global market for 5-aminosalicylates drugs indicates that the revenue share is likely to increase significantly during the forecast period. A group of drugs called aminosalicylates (5-ASAs) lessens inflammation in the large and small intestines. The first-line treatment for mild to severe ulcerative colitis is typically 5-ASAs. 

Key Takeaways: 

• The increasing number of patients with ulcerative colitis and Crohn's disease is driving the market revenue share.
• According to a survey, 54% of IBD patients in Europe and the United States were diagnosed with Ulcerative Colitis. 
• In the United States, the prevalence of ulcerative colitis and Crohn's disease, collectively known as inflammatory bowel disease (IBD), affects more than 1.6 million individuals. It is estimated that around 70,000 new cases of IBD are diagnosed annually in the country.

Request a Sample Copy of the Research Report: https://www.growthplusreports.com/inquiry/request-sample/5aminosalicylates-drugs-market/9015

                                         5-Aminosalicylates Drugs Market Scope

Report Attribute	Details
CAGR	3.5%
Base Year for Estimation	2022
Forecast Period	2023 to 2031
Historical Year	2021
Segments Covered	Type ,Indication and Region
Regional Scope	North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa

Competitive Landscape

A list of the companies operating in the global market for 5-aminosalicylates drugs includes: 

• Tillotts Pharma AG.
• WALLACE PHARMA
• Takeda Pharmaceutical Company Limited
• Abbvie, Inc.
• Cosmo Pharmaceuticals NV 

Market Drivers and Restraints: 

The global 5-aminosalicylates drugs market revenue is driven by the increasing prevalence of diseases like ulcerative colitis and Crohn's disease. Furthermore, the increasing measures taken by the government to advance healthcare and technologies for better diagnostics and therapeutics are resulting in market revenue growth. 

Market Segmentation: 

• Based on type, the global 5-aminosalicylates drugs market is segmented into sulfasalazine, mesalazine, olsalazine, and others. 
• Based on indication, the global 5-aminosalicylates drugs market is segmented into ulcerative colitis, inflammatory bowel disease, and others. 

Segmentation By Indication

Based on the indications, the ulcerative colitis segment dominates the global 5-aminosalicylates drugs market with the largest revenue share. This large revenue share is attributed to a large patient pool and the introduction of new medications for ulcerative colitis by various market participants. 

Request for Customization –https://www.growthplusreports.com/inquiry/customization/5-aminosalicylates-drugs-market/9015

Regional Growth Analytics

Based on the region, North America, with the largest revenue share, dominates the global 5-aminosalicylates drugs market. This regional revenue expansion is achievable by the region's better healthcare practices, high treatment rates, and increased prescription of novel medicines. This is due to the region's huge number of strong market participants and the various strategic actions they performed there.

Report Coverage 

Growth Plus Reports conducted extensive market research on the 5-aminosalicylates drugs market globally. We examined the fundamental market characteristics, significant investment opportunities, regional growth patterns, ten-year revenue estimates, competing market players, and mergers and acquisitions.

Table of Content

1. INTRODUCTION
   1. Market Ecosystem
   2. Timeline Under Consideration
      1. Historical Years – 2021
      2. Base Year – 2022
      3. Forecast Years – 2023 to 2031
   3. Currency Used in the Report
2. RESEARCH METHODOLOGY 
   1. Research Approach
   2. Data Collection Methodology
   3. Data Sources
      1. Secondary Sources 
      2. Primary Sources
   4. Market Estimation Approach
      1. Bottom Up
      2. Top Down 
   5. Market Forecasting Model
   6. Limitations and Assumptions
3. PREMIUM INSIGHTS
   1. Current Market Trends (COVID-19 Perspective)
   2. Key Players & Competitive Positioning (2022)
   3. Regulatory Landscape
4. MARKET DYNAMICS
   1. Drivers
   2. Restraints/Challenges
   3. Opportunities
5. GLOBAL 5-AMINOSALICYLATES DRUGS MARKET - ANALYSIS & FORECAST, BY TYPE
   1. Sulfasalazine
   2. Mesalazine
   3. Olsalazine
   4. Others
6. GLOBAL 5-AMINOSALICYLATES DRUGS MARKET - ANALYSIS & FORECAST, BY INDICATION
   1. Ulcerative Colitis
   2. Inflammatory Bowel Disease
   3. Others

5-AMINOSALICYLATES DRUGS MARKET TOC

Buy this Premium Research Report: https://www.growthplusreports.com/checkout-9015

VALUE PROPOSITIONS RELATED TO THE REPORT:

• Powered with Complimentary Analyst Hours and Expert Interviews with Each Report
• Comprehensive quantitative and qualitative insights at segment and sub-segment level
• Covid 19 impact trends and perspective
• Granular insights at global/regional/country level
• Deep-rooted insights on market dynamics (drivers, restraints, opportunities) and business environment
• Blanket coverage on competitive landscape
• Winning imperatives
• Exhaustive coverage on 'Strategic Developments' registered by leading players of the market.

CUSTOMIZATION OPTIONS:

• Distributor Landscape Assessment
• Pricing Intelligence
• Customer Base Assessment
• Investment & Initiatives Analysis
• 'Business Profile' of Key Players

Schedule a call with our analyst: https://appoint.ly/s/salesZ3Jvd3RocGx1c3JlcG9ydHMuY29t/introduction

Visit our report store at - https://www.growthplusreports.com/report-store

Browse more latest healthcare reports:

Knee Arthrodesis Implants Market by Product Type (Standard Implants, Customized Implants), Technique (Long Intramedullary Nail, Short Intramedullary Nail), Implantation Technique (Cemented Implantation), End User (Hospitals & Clinics, Emergency Service Centers) – Global Outlook & Forecast 2023-2031

Oncology Imaging Software Market by Indication (Breast Cancer, Lung Cancer), Imaging Technique (CT Scan, MRI), Mode of Delivery (On-cloud, On-premise) – Global Outlook & Forecast 2023-2031

Acute Kidney Injuries Market by Type of Injuries (Pre-renal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injuries, Post-renal Acute Kidney Injuries), Treatment (Drug Therapy, Dialysis) - Global Outlook and Forecast 2023-2031

Mirvetuximab Soravtansine Market by Indication (Ovarian Cancer, Fallopian Tube Carcinoma), Distribution Channel (Hospital Pharmacies, Retail Pharmacies) – Global Outlook & Forecast 2023-2031

Calcium Homeostasis Drugs Market by Drug Class (Calcium Metabolism Modifiers, Parathyroid Hormone Analogs), Indication (Hypocalcemia, Hypercalcemia), Distribution Channel (Hospitals Pharmacies, Retail Pharmacies) – Global Outlook & Forecast 2023-2031

Unleashing the Power of Innovation in Med Tech https://growthplusmedtechroundup.com/

About Us:

Growth Plus Reports is part of GRG Health, a global healthcare knowledge service company. We are proud members of EPhMRA (European Pharmaceutical Marketing Research Association).

Growth Plus portfolio of services draws on our core capabilities of secondary & primary research, market modelling & forecasting, benchmarking, analysis and strategy formulation to help clients create scalable, ground-breaking solutions that prepare them for future growth and success.

We were awarded by the prestigious CEO Magazine as "Most Innovative Healthcare Market Research Company in 2020.

            Manan Sethi
Director, Market Insights
Email: sales@growthplusreports.com
256 Chapman Road
STE 105-4, Newark,
New Castle - 19702, USA
Phone no: +1 888 550 5009
Web: https://www.growthplusreports.com/